Exposure to Per- and Polyfluoroalkyl Substances and Risk of Psoriasis: A Population-Based Study

PFAS are a group of synthetic chemicals that have been reported to be associated with adverse health outcomes. However, the relationship of PFAS exposure with psoriasis risk has not been reported. Utilizing data from the 2003–2018 NHANES, we explored the relationship of PFAS exposure with psoriasis...

Full description

Bibliographic Details
Published in:	Toxics
Main Authors:	Qing Zhang, Mengyue Zhang, Cunxi Zhao
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Subjects:	per- and polyfluoroalkyl substances psoriasis mixture analysis NHANES
Online Access:	https://www.mdpi.com/2305-6304/12/11/828

Similar Items

Age-specific associations between per- and polyfluoroalkyl substances exposure and metabolic syndrome: a cross-sectional study
by: Luanxun Lin, et al.
Published: (2025-05-01)

Hunting Metabolic Biomarkers for Exposure to Per- and Polyfluoroalkyl Substances: A Review
by: Xue Ma, et al.
Published: (2024-07-01)

Relationship between per-fluoroalkyl and polyfluoroalkyl substance exposure and insulin resistance in nondiabetic adults: Evidence from NHANES 2003–2018
by: Peng Jia, et al.
Published: (2024-11-01)

Effects of Per- and Polyfluoroalkylated Substances on Female Reproduction
by: María Estefanía González-Alvarez, et al.
Published: (2024-06-01)

Exploring the Association Between Per‐ and Polyfluoroalkyl Substances Exposure and the Risk of Stroke: A Systematic Investigation Using NHANES Data Analysis, Network Toxicology and Molecular Docking Approaches
by: Yanjie Jiang, et al.
Published: (2025-10-01)

Environmental exposure to mixtures of per- and polyfluoroalkyl substances in Northeast China: exploring links to nodular goiter and papillary thyroid carcinoma
by: Ziqing Sun, et al.
Published: (2025-06-01)

Per and polyfluoroalkyl substances affect thyroid hormones for people with a history of exposure from drinking water
by: Taylor S. Noyes, et al.
Published: (2025-04-01)

Association between exposure to bisphenols and per- and polyfluoroalkyl substances and behavioral problems among Chinese preschoolers
by: Ruo-yu Li, et al.
Published: (2025-09-01)

Associations of per- and polyfluoroalkyl substances (PFAS) and their mixture with risk of rheumatoid arthritis in the U.S. adult population
by: Jian-Chao Qiao, et al.
Published: (2024-04-01)

Association of exposure to per- and polyfluoroalkyl substances with hemoglobin and hematocrit during pregnancy
by: Fengzhen Cui, et al.
Published: (2022-12-01)

Prenatal per- and polyfluoroalkyl substances exposure and gut microbiota of infants: A prospective cohort study
by: Honglei Ji, et al.
Published: (2024-01-01)

Association between per- and polyfluoroalkyl substances exposure and childhood obesity: an umbrella review
by: Randy Howard Brataatmaja, et al.
Published: (2025-10-01)

Environmental occurance, human exposure, and metabolism of per- and polyfluoroalkyl substances—a review
by: Yifei Cao, et al.
Published: (2025-01-01)

Effects and possible mechanisms of per- and polyfluoroalkyl substances exposure on human thyroid function
by: Chenyang LIU, et al.
Published: (2023-05-01)

Research progress on exposure to per- and polyfluoroalkyl substances and adverse pregnancy outcomes
by: Li LU, et al.
Published: (2025-06-01)

Exposure to per- and polyfluoroalkyl substances and high-throughput proteomics in Hispanic youth
by: Jiawen Carmen Chen, et al.
Published: (2024-04-01)

Association between Perfluoroalkyl and polyfluoroalkyl substances exposure and hypercholesterolemia among U.S. adults: A cross-sectional study
by: Junyi Wang, et al.
Published: (2025-09-01)

Associations between per- and polyfluoroalkyl substances exposure and renal function as well as poor prognosis in chronic kidney disease patients
by: Jiayin Wang, et al.
Published: (2025-12-01)

Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
by: Xinyuan Zhang, et al.
Published: (2023-05-01)

Per- and Polyfluoroalkyl Substances (PFAS) in Consumer Products: An Overview of the Occurrence, Migration, and Exposure Assessment
by: Yang Yang, et al.
Published: (2025-02-01)

Review on per- and polyfluoroalkyl substances exposure, thyroid function, and mechanisms of action in mothers and infants
by: Lemin GONG, et al.
Published: (2024-12-01)

Novel and legacy per- and polyfluoroalkyl substances in humans: Long-term temporal variability and metabolic perturbations
by: Che-Jung Chang, et al.
Published: (2025-07-01)

Association of per- and polyfluoroalkyl substances with gout risk: a cross-sectional analysis of NHANES 2007–2018 data emphasizing mixture effects
by: Haixin Feng, et al.
Published: (2025-02-01)

Possible mechanisms of toxic effects of per-and polyfluoroalkyl substances exposure on thyroid
by: Luyang HE, et al.
Published: (2023-11-01)

Hydrothermal alkaline treatment for efficient degradation of per- and polyfluoroalkyl substances
by: ZHANG Qiang, et al.
Published: (2025-03-01)

Prenatal exposure to per- and polyfluoroalkyl substances and infant sleep disturbance: A prospective cohort study
by: Yun Huang, et al.
Published: (2023-08-01)

Unveiling per- and polyfluoroalkyl substance contamination in Chinese paper products and assessing their exposure risk
by: Yan-Fei Chen, et al.
Published: (2024-03-01)

Prenatal exposure to per-and polyfluoroalkyl substances and child executive function: Evidence from the Shanghai birth cohort study
by: Xuchen Yang, et al.
Published: (2024-01-01)

Association between per- and polyfluoroalkyl substances exposure and blood pressure: From epidemiological evidence to mechanistic insights
by: Ziwen An, et al.
Published: (2025-09-01)

An insight into the environmental and human health impacts of per- and polyfluoroalkyl substances (PFAS): exploring exposure pathways and their implications
by: Mohammad Hadi Dehghani, et al.
Published: (2025-06-01)

Association between exposure to per- and polyfluoroalkyl substances (PFAS) and chronic cough in American adults: Results from NHANES 2003–2012
by: Wenlong Wu, et al.
Published: (2025-02-01)

Accelerated placental aging mediated the association between prenatal exposure to per- and polyfluoroalkyl substances and small-for-gestational age newborns
by: Yijun Fan, et al.
Published: (2025-07-01)

The effect and potential mechanisms of per- and polyfluoroalkyl substances (PFAS) exposure on kidney stone risk
by: Ying Cui, et al.
Published: (2025-04-01)

Effect modification by maternal vitamin D status in the association between prenatal exposure to per- and polyfluoroalkyl substances and neurodevelopment in 2-year-old children
by: Yu Gao, et al.
Published: (2024-03-01)

Associations between per- and polyfluoroalkyl substance exposure and the prevalence of myopia in adolescents: the mediating role of serum albumin
by: Xuewei Li, et al.
Published: (2025-06-01)

Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights
by: George Briassoulis, et al.
Published: (2025-07-01)

Combination of suspect and nontarget screening with exposure assessment for per- and polyfluoroalkyl substance prioritization in Chinese municipal wastewater
by: Hongxin Mu, et al.
Published: (2025-04-01)

The association between per- and polyfluoroalkyl substances and biological aging among middle and older age adults: The moderating effect of caffeine
by: Shuxiang Yan, et al.
Published: (2025-09-01)

Per- and polyfluoroalkyl substances alter innate immune function: evidence and data gaps
by: Drake W. Phelps, et al.
Published: (2024-12-01)

Integration of ultrashort-chain compounds into the biomonitoring of per- and polyfluorinated substances in human plasma and serum
by: Shun-Hsin Liang, et al.
Published: (2024-05-01)